A Mixed Meal Tolerance Test Study to Evaluate the Pharmacokinetics and Pharmacodynamics of LY900014 Compared to Humalog Following a Single Dose in Adults With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Insulin lispro (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 28 Mar 2018 Planned End Date changed from 26 Sep 2018 to 1 Jun 2018.
- 28 Mar 2018 Planned primary completion date changed from 26 Sep 2018 to 1 Jun 2018.
- 28 Mar 2018 Status changed from not yet recruiting to recruiting.